MedPath

Pharmaceutical management of elderly patients in the perioperative setting

Not Applicable
Conditions
Polymedication of elderly risk patients
Registration Number
DRKS00014621
Lead Sponsor
Klinik und Poliklinik für Anästhesiologie
Brief Summary

Elderly, multimorbid patients represent a growing proportion of patients who have to undergo surgical intervention in hospital. Multimedication and potentially inadequate medication, i.e. drugs that may have unfavourable effects due to altered pharmacodynamics in the elderly, increase the perioperative risk of this vulnerable patient group. The aim of the research project "Pharmaceutical Management of Elderly Risk Patients in the Perioperative Setting" (PHAROS) was to investigate whether preoperative optimisation of long-term medication can improve the appropriateness of medication in elderly risk patients, reduce drug-related problems and prevent information losses between the outpatient and inpatient sectors. This project was designed as a pilot study in a before-and-after design. Patients over 64 years of age with an increased perioperative risk, calculated from the disease burden and invasiveness of the upcoming surgery (POSPOM score) as well as a permanent intake of more than four medications were included in the study. The intervention consisted of a pharmaceutical medication history a few days after inclusion in the study, a subsequent pharmaceutical medication analysis and - if medication-related problems or potentially inadequate medication were identified - a recommendation to the general practitioners to optimise the patient's long-term medication by changing it preoperatively. The time points for data collection were 3 weeks preoperatively, admission and discharge from hospital, and 3 months postoperatively. The primary endpoint was a change in the Medication Appropriate Index between the control and intervention groups. Secondary endpoints were the occurrence of postoperative complications, the frequency of medication-related problems (AbP) and potentially inadequate medication (PIM), patient satisfaction with outpatient and inpatient care, the correct medication during transitions in the treatment process (medication reconciliation) and health-related quality of life. It was shown that neither the appropriateness of medication nor the secondary endpoints differed between the control and intervention groups. In 34% of the cases, a change in medication was recommended, but this only took place in 6% percent. Barriers to the implementation of the intervention were mainly identified as difficult intersectoral communication and insufficient time between medication analysis and planned surgery. The pharmaceutical intervention was assessed as positive and necessary by all professional groups and patients involved. The further development of a suitable intervention that can sustainably reduce the risk of drug-related problems in the perioperative setting in clinical routine should remain the focus of future scientific projects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

patients of the University Medical Centre Hamburg-Eppendorf
- age > 65 years
- planned surgery in not less than 21 days
- POSPOM-Score >20 (risk patients)
- long-term medication >/= 5 drugs

Exclusion Criteria

- refusal of confession
- emergency surgery
- surgery with planned postoperative intensive medical care
- cerebral and ophtalmological surgery as well as surgerys with planned inpatient care less than one day
- drug abuse (intravenous, in medical history or current)
- psychosis
- chronically abuse of benzodiazepines
- Parkinson's disease
- illiteracy
- blindness/deafness
- poor knowledge of the German language
- preexisting mental disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medication Appropriatness Index (MAI) - at T1 (patients’ initial visit), T3 (after admission to hospital), T4 (immediately after discharge from hospital) and T5 (three months after discharge)<br><br>
Secondary Outcome Measures
NameTimeMethod
- Occurrence of postoperative complications <br>- Correct recording of the medication at the interfaces (Medication Reconciliation) <br>- satisfaction with medical care (outpatient: ZAPA/ inpatient: ZUF-8) <br>- occurrence and frequency of DRP and PIM <br>- health-related quality of life (SF-12)<br>- treatment adherence (MARS-D)
© Copyright 2025. All Rights Reserved by MedPath